K. Kaneko

Angiotensin Receptor Antagonist Regresses Left Ventricular Hypertrophy Associated with Diabetic Nephropathy in Dialysis Patients

H. Takane, Y. Kanno, Hiromichi Suzuki, 2004, Journal of cardiovascular pharmacology.

Mid-term predictive value of calciprotein particles in maintenance hemodialysis patients based on a gel-filtration assay.

M. Kuro-o, Y. Mizuno, S. Nishimura, 2020, Atherosclerosis.

Comparison of the Effects of Angiotensin Receptor Antagonist, Angiotensin Converting Enzyme Inhibitor, and their Combination on Regression of Left Ventricular Hypertrophy of Diabetes Type 2 Patients on Recent Onset Hemodialysis Therapy

H. Takane, Y. Kanno, Hiromichi Suzuki, 2004, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

The renoprotective effect and safety of a DPP-4 inhibitor, sitagliptin, at a small dose in type 2 diabetic patients with a renal dysfunction when changed from other DPP-4 inhibitors: REAL trial

Satoko Nakamura, Y. Noguchi, Hajime Hasegawa, 2018, Clinical and Experimental Nephrology.

ACE inhibition reduces left ventricular mass independent of pressure without affecting coronary flow and flow reserve in spontaneously hypertensive rats.

E. Núñez, E. Frohlich, D. Sušić, 1997, The American journal of the medical sciences.

Losartan reduces cardiac mass and improves coronary flow reserve in the spontaneously hypertensive rat

E. Núñez, E. Frohlich, D. Sušić, 1996, Journal of hypertension.

Preserved cardiac performance with reduced left ventricular mass in conscious exercising spontaneously hypertensive rats

E. Frohlich, F. Soria, D. Aristizábal, 1994, Journal of hypertension.

Cilnidipine is as effective as benazepril for control of blood pressure and proteinuria in hypertensive patients with benign nephrosclerosis.

H. Suzuki, Y. Kanno, G. Rose, 2001, Hypertension research : official journal of the Japanese Society of Hypertension.